Yes IMU's initial results appear to be promising.
Cancer is not going to be cured by any one approach and we need as many promising and complementary approaches as possible to be advanced. IMU and RAC are not in competition with each other in anyway and the success of IMU benefits RAC and the success of RAC benefits IMU.
Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-53
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.005(0.34%) |
Mkt cap ! $249.7M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.50 | $1.46 | $129.2K | 87.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7418 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 38353 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |